Wednesday’s insider buys and sells: Hepion insiders invest $800K
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) executives and directors made significant insider purchases on August 3, 2026. Executive Chairman Vincent S. LoPriore led the buys with a $500,000 investment, acquiring 8,000,000 shares at $0.05 each through Gravitas Capital LP and an additional 2,000,000 shares via the Invictus Capital Advisors Pension Plan.
Interim CEO Gary S. Stetz also invested $100,000 by purchasing 2,000,000 shares at the same price. Director Michael J. Purcell bought 2,000,000 shares and 2,000,000 warrants for $100,000. COO and director Sireesh Appajosyula purchased 2,000,000 shares and 2,000,000 warrants for $100,000. CEO Appajosyula also acquired 2,000,000 warrants.
ProFrac Holding Corp. (NASDAQ:ACDC) director Dan H. Wilks made two-day purchases totaling $3,616,641, while Life Time Group Holdings, Inc. (NASDAQ:LTH) saw its biggest insider sale with Green LTF Holdings II selling approximately $220.9 million worth of shares. Finally, Twilio Inc. (NASDAQ:TWLO) director Andrew Stafman sold 500,000 shares for $123,540,000.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
